Semaglutide Dosage Guide
Complete guide to Semaglutide dosing protocols, administration methods, and safety considerations for research purposes.
NOT Medical Advice
The dosage and calculator information provided is for educational and research purposes only. Peptides are not approved by the FDA for human use. Individual responses vary significantly. Always consult with a qualified healthcare professional before making any decisions related to peptide research or use.
Dosage Overview
Dose Range
250 mcg - 2.4 mg
Route
subcutaneous
Frequency
Weekly
Cycle Length
12-52 weeks
Reconstitution
Vial Size
2 mg
BAC Water
1.0 ml
Concentration
2,000 mcg/ml
Detailed Dosage Information
Wegovy (weight loss): Start at 0.25mg weekly, titrate up to 2.4mg weekly over 16-20 weeks. Ozempic (diabetes): 0.25mg to 1mg weekly. Research protocols vary.
Administration Method
Subcutaneous injection once weekly, typically in abdomen, thigh, or upper arm. Rybelsus is taken orally on empty stomach. Dose titration is essential to minimize GI side effects.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Quick Calculator
Concentration: 2,000 mcg/ml
Volume to inject: 0.13 ml
Syringe units (U-100): 12.5 units
Pre-filled with Semaglutide defaults. Adjust values as needed.
Side Effects to Monitor
Common: nausea, vomiting, diarrhea, constipation, abdominal pain. These typically decrease over time. May cause injection site reactions.
Safety Considerations & Risks
Contraindicated with personal/family history of medullary thyroid carcinoma or MEN2 syndrome. Risk of pancreatitis, gallbladder disease, and potential retinopathy progression in diabetics.